網宿科技(300017.SZ):以約1.21億元回購上海雲宿26.73%股權並解除相關擔保義務
格隆匯11月23日丨網宿科技(300017.SZ)公佈,目前,鑑於《投資合同》約定的第二次回購交割日臨近,2021年11月23日,公司、上海雲宿及國開基金簽訂了《股權轉讓合同》。根據《股權轉讓合同》,公司以人民幣12073.5萬元向國開基金回購其持有的上海雲宿26.73%股權並解除此次被轉讓股權相對應的擔保義務。
此次回購事宜繫上海雲宿前期通過增資引進財務投資者後續安排的具體實施,無需另行提交公司董事會、股東大會審議。此次交易不構成關聯交易、也不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.